|Subscribe NowLogin
Ground News Logo
Jun 13, 2021SUBSCRIBE NOW

Medicare copays for new Alzheimer's drug could reach $11,500

A new $56,000-a-year Alzheimer’s drug would raise Medicare premiums broadly, and some patients who are prescribed the medication could face copayments of about $11,500 annually, according to a research report published Wednesday.
Medicare copays for new Alzheimer's drug could reach $11,500
2 days ago|Washington, United States

BIAS DISTRIBUTION

31 of these news sources are bias rated
19 are CENTER
L 36%
C 61%
 
Vox
Yahoo News
abc News
npr
Pioneer Press
+7
Associated Press News
KCRA 3
WPLG
KTLA 5
+16
The Billings Gazette
ALL ARTICLES
Yahoo News
Yahoo NewsL

Medicare copays for new Alzheimer's drug could reach $11,500

A new $56,000-a-year Alzheimer’s drug would raise Medicare premiums broadly, and some patients who are prescribed the medication could face copayments of about $11,500 annually, according to a research report published Wednesday. The drug, called Aduhelm, was approved by the Food and Drug Administration only this week. It's the first Alzheimer's medication in nearly 20 years, though it doesn't cure the life-sapping neurological condition.

3 days ago|Los Angeles, United States
abc News
abc NewsL

Medicare copays for new Alzheimer's drug could reach $11,500

A new report says the $56,000 Alzheimer’s drug approved this week would raise Medicare premiums broadly

3 days ago|United States
Associated Press News
Associated Press NewsC

Medicare copays for new Alzheimer's drug could reach $11,500

WASHINGTON (AP) — A new $56,000-a-year Alzheimer’s drug would raise Medicare premiums broadly, and some patients who are prescribed the medication could face copayments of about $11,500 annually, according to a research report published Thursday.

3 days ago|United States
npr
nprL

Medicare Copays For New Alzheimer's Drug Could Reach $11,500 Annually

Some advisors to the Food and Drug Administration have quit over the drug which critics say has questionable benefits. The FDA said it can reduce clumps of plaque in the brain and may slow dementia.(Image credit: Biogen via AP)

3 days ago|Washington, United States
KCRA 3
KCRA 3C

Medicare copays for new Alzheimer's drug could reach $11,500

"At this price, the cost of this one drug alone could top all others covered by Medicare, if it is used widely."

2 days ago|Sacramento, United States
Pioneer Press
Pioneer PressL

Medicare copays for new Alzheimer’s drug could reach $11,500

By RICARDO ALONSO-ZALDIVAR and MATTHEW PERRONEWASHINGTON (AP) — A new $56,000-a-year Alzheimer’s drug would raise Medicare premiums broadly, and some patients who are prescribed the medication could face copayments of about $11,500 annually, according to a research report published Thursday.The drug, called Aduhelm, was approved by the Food and Drug Administration this week and quickly sparked controversy over its price-tag and questionable bene…

2 days ago|St Paul, United States
Star Tribune
Star TribuneL

Medicare copays for new Alzheimer's drug could reach $11,500

A new $56,000-a-year Alzheimer's drug would raise Medicare premiums broadly, and some patients who are prescribed the medication could face copayments of about $11,500 annually, according to a research report published Thursday.

3 days ago|Minneapolis, United States
The Mercury news
The Mercury newsL

Medicare copays for new Alzheimer’s drug could reach $11,500

By Ricardo Alonso-Zaldivar and Matthew Perrone | Associated PressWASHINGTON — A new $56,000-a-year Alzheimer’s drug would raise Medicare premiums broadly, and some patients who are prescribed the medication could face copayments of about $11,500 annually, according to a research report published Thursday.The drug, called Aduhelm, was approved by the Food and Drug Administration this week and quickly sparked controversy over its price-tag and que…

2 days ago|San Jose, United States
WHDH
WHDHL

Medicare copays for new Alzheimer’s drug could reach $11,500

WASHINGTON (AP) — A new $56,000-a-year Alzheimer’s drug would raise Medicare premiums broadly, and some patients who are prescribed the medication could face copayments of about $11,500 annually, according to a research report published Thursday.The drug, called Aduhelm, was approved by the Food and Drug Administration this week and quickly sparked controversy over its price-tag and questionable benefits.It’s the first Alzheimer’s medication in …

3 days ago|
WKMG
WKMG

Medicare copays for new Alzheimer's drug could reach $11,500

A new $56,000-a-year Alzheimer’s drug would raise Medicare premiums broadly, and some patients who are prescribed the medication could face copayments of about $11,500 annually, according to a research report published Wednesday.The drug, called Aduhelm, was approved by the Food and Drug Administration only this week. It's the first Alzheimer's medication in nearly 20 years, though it doesn't cure the life-sapping neurological condition. Some e…

3 days ago|
COVERAGE DETAILS

BIAS DISTRIBUTION

31 of these news sources are bias rated
19 are CENTER
L 36%
C 61%
 
Vox
Yahoo News
abc News
npr
Pioneer Press
Star Tribune
The Mercury news
WHDH
Koco News5
WISH-TV
Tucson
Associated Press News
KCRA 3
WPLG
KTLA 5
WMUR
KETV
WTAE
WFAA 8abc
First Coast
nwitimes.com
13 WTHR
+9
The Billings Gazette
Total News Sources70Leaning Left11 sourcesLeaning Right1 sourceCenter19 sourcesLast Updated2 days ago
0
TOPICS
SIMILAR STORIES